Literature DB >> 9548456

CD8+ T cells clear influenza virus by perforin or Fas-dependent processes.

D J Topham1, R A Tripp, P C Doherty.   

Abstract

Influenza virus infection is controlled in CD4-depleted mice that are also defective for the expression of either Fas (Fas-/-) or perforin (P-/-). Virus-immune P+/+ and P-/- CD8+ T cells can thus function in, respectively, a Fas-/- or Fas+/+ lung environment. The obvious question is whether the P-/- CD8+ set is effective in Fas-/- mice, a conclusion that would tend to favor cytokine secretion as the mode of virus clearance. Short term chimeras were made with P-/- bone marrow, P+/+ or P-/- T cells, and Fas+/+ or Fas-/- irradiated recipients. While the P+/+ CD8+ population cleared the virus from Fas+/+ and Fas-/- respiratory epithelium, the P-/- effectors were operational only if there was the potential for Fas to be expressed on radiation-resistant lung cells. Target cell destruction mediated via the Fas or perforin pathways is clearly the primary mechanism used by CD8+ T cells to terminate this viral pneumonia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9548456

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  228 in total

1.  Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

Authors:  S A Ghanekar; L E Nomura; M A Suni; L J Picker; H T Maecker; V C Maino
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge.

Authors:  G T Belz; W Xie; J D Altman; P C Doherty
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system.

Authors:  B Parra; M T Lin; S A Stohlman; C C Bergmann; R Atkinson; D R Hinton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

5.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 6.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

7.  Tissue exit: a novel control point in the accumulation of antigen-specific CD8 T cells in the influenza a virus-infected lung.

Authors:  Silke Jennrich; Michael H Lee; Rachel C Lynn; Kristofer Dewberry; Gudrun F Debes
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 8.  T cell memory in the lung airways.

Authors:  David L Woodland; Iain Scott
Journal:  Proc Am Thorac Soc       Date:  2005

9.  Fas (CD95)-dependent cell-mediated immunity to Listeria monocytogenes.

Authors:  E R Jensen; A A Glass; W R Clark; E J Wing; J F Miller; S H Gregory
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 10.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity.

Authors:  Joshua S M Woodworth; Samuel M Behar
Journal:  Crit Rev Immunol       Date:  2006       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.